论文部分内容阅读
目的:探讨垂体后叶素治疗肺结核咯血的临床疗效。方法:选取我院接收的98例肺结核咯血患者作为本次的研究对象,以治疗方式的不同将所有患者分为观察组和对照组,每组49例,对照组行常规治疗,观察组在此基础上加用垂体后叶素治疗,比较两组患者的临床疗效。结果:两组患者治疗总有效率、止血时间比较有较大差异(p<0.05),两组患者治疗期间均无严重不良反应发生。结论:在常规治疗的基础上给予肺结核咯血患者垂体后叶素治疗可有效的提高治疗效果,其临床应用价值较高,可推广应用。
Objective: To investigate the clinical efficacy of pituitrin in the treatment of hemoptysis of pulmonary tuberculosis. Methods: A total of 98 patients with pulmonary tuberculosis and hemoptysis received in our hospital were selected as the study subjects. All the patients were divided into observation group and control group according to the different treatment methods. Each group had 49 cases, while the control group received routine treatment. Based on the use of pituitrin plus treatment, the clinical efficacy of two groups were compared. Results: The total effective rate and the bleeding time of the two groups were significantly different (p <0.05). No serious adverse reactions occurred in the two groups during treatment. Conclusion: The treatment of hemoptysis in patients with tuberculosis hemoptysis on the basis of routine treatment can effectively improve the therapeutic effect, and its clinical value is higher and can be popularized and applied.